HS Code 30043190 โ Other medicaments containing insulin (retail)
Chapter 30 (Pharmaceutical Products) ยท Heading 3004 (Medicaments put up in measured doses or for retail sale) ยท Last updated: May 2026 ยท Source: Indian Customs (DGFT) Records
HS Code 30043190 (Other medicaments containing insulin (retail)) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $472.5M across 3,129 shipments, this code covers 49 distinct pharmaceutical products exported by 134 Indian manufacturers to 97 countries. The leading product under this classification is Gliclazide at $197.6M, followed by Liraglutide and Glimepiride.
The top importing markets include United States, Malta, Canada. The top 5 products account for 91.6% of total trade under this code. Average transaction value is $151.0K. Leading exporters include NOVARTIS PHARMA AG and M/S. NOVO NORDISK A/S. Data sourced from Indian Customs (DGFT) shipping bill records.

Products Exported Under HS Code 30043190
49 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Gliclazide | $197.6M | 734 | $21.83 | 41 |
| #2 | Liraglutide | $123.1M | 32 | $219.77 | 15 |
| #3 | Glimepiride | $49.2M | 310 | $11.57 | 36 |